Follow us

Subscribe to our Newsletters

Search News Archives

 


Subscibe to our YouTube channel

 

 

E-Newsletter Month  
Lab Bulletin Monthly Update August view archive
Microscopy & Image Analysis September view archive
Separation Science August view archive
Weekly Update September (3) view archive

new all Newsletter Banner

For further information or to sign up to receive any of our E-Newsletters click here


Tecan announces major OEM agreement with global diagnostics company for development and supply of a dedicated diagnostics instrument

tecan logo

  • Agreement building upon established OEM partnership between both companies
  • Concept development and feasibility testing already successfully completed
  • Tecan signed a ten-year supply agreement with a purchase commitment by the diagnostic company
  • Upon successful completion of development, based on Tecan's expectations sales potential is estimated to be more than CHF 80 millions over the first five years

The Tecan Group (SIX Swiss Exchange: TECN) today announced a major OEM agreement with a global diagnostics company for the development and supply of a dedicated diagnostics instrument. Under the global agreement, Tecan will develop and supply a fully automated instrument and a corresponding plastic consumable. The agreement is building on an established partnership between both companies.

The development agreement follows a concept development and feasibility testing phase that was already successfully completed. During the development phase Tecan will pre-finance and capitalize the development costs of the next generation instrument. The first half of the development costs will be repaid by the diagnostic company upon launch of the instrument and the remaining half one year after launch. In addition to the development agreement both companies signed a ten-year supply agreement with a purchase commitment by the diagnostic company. Upon successful completion of development, based on Tecan's expectations the sales potential is estimated to be more than CHF 80 millions over the first five years. Tecan expects to ship first instruments for the commercial launch to the diagnostics company in late 2012.

Thomas Bachmann, CEO of Tecan, said: "We are proud to have signed this major OEM agreement with one of our existing OEM partners to develop the next generation dedicated instrument. For Tecan this OEM agreement significantly broadens our market opportunity as the instrument will be marketed globally and will penetrate new markets."  

About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).




Can't find what you are looking for?

Search by company, product or location

Company Name:

Location:

Product:



Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have a product enquiry, please contact the supplier directly.


Lab Bulletin is published by newleaf marketing communications ltd


Exhibitions & Events
«  »
SMTWTFS
 123456
78910111213
14151617181920
21222324252627
282930